Evoke Pharma Investor Relations Material

Evoke Pharma Inc. is a specialty pharmaceutical company focused on the development and commercialization of treatments for gastrointestinal (GI) disorders. The company’s primary focus is on addressing unmet medical needs related to conditions that affect GI motility. Evoke Pharma's products are designed to offer novel delivery methods to improve patient outcomes, particularly for those with chronic and debilitating GI issues. The company's approach involves enhancing therapeutic efficacy and patient convenience through innovative formulations. The company is headquartered in Solana Beach, California, and its shares are listed on the NASDAQ.